How WebRTC will revolutionize the healthcare industry
One consistent trend that has emerged in the healthcare industry is the idea of using telehealth services to monitor patients outside of the traditional clinic setting.
While most firms understand the need for and potential benefits of this service, the issue that many companies have is how to implement it in an increasingly security-conscious world.
WebRTC is one method that is gaining traction in this field, as it offers a cost-effective and a secure method of implementing streaming video services online with a minimum implementation costs.
WebRTC’s Low Cost, Ease of Implementation and Use
Many industry competitors, such as the developers of proprietary video and communications hardware and software, haven't shown too much concern over the threat of WebRTC, even as the list of companies using this service continues to grow.
The transport layer technology that WebRTC is built upon offers real time voice, video, and data sharing as a native function of any current internet browser, without requiring complicated plugins, codecs or software like Skype or GotoMeeting.
This doesn't just give patients and doctors an easy (click to call) and secure method of video communication. It also allows the developers of medical applications, doctor and hospital websites the ability to easily implement these higher-quality video communication features into their services at a minimal cost.
Most developers and proponents agree that because of these desirable benefits, WebRTC will be a game-changing piece of technology that will soon become a standard function in modern web browsers.
WebRTC is Becoming the Standard
These proponents of WebRTC have won major battles in having their standards become the go-to choice for online video communications. This includes an upcoming ratification by the World Wide Web Consortium (W3C), which is the body responsible for setting the de facto standards that govern the construction of web sites and web applications, as well as backing from companies that include Google, Firefox, Opera, and most recently Microsoft.
What does this mean for telehealth in the future? The WebRTC standard will continue to grow and improve, which will prompt greater adoption rates among telehealth companies.
Given the low cost of implementation and security of the connection, American enterprises are projected to spend less than 20 per cent of their current spending levels on telecom services within five years, which in turn will help lower medical costs.
Click here to read the latest edition of Healthcare Global magazine!
Introducing Dosis - the AI powered dosing platform
Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works.
When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing.
The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced.
What is the Strategic Anemia Advisor?
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease.
SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool.
What else is Dosis working on?
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs.
What are Dosis' strategic goals for the next 2-3 years?
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.
What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.